18.03
0.75 (4.34%)
| Previous Close | 17.28 |
| Open | 17.63 |
| Volume | 695,390 |
| Avg. Volume (3M) | 297,312 |
| Market Cap | 684,106,880 |
| Price / Sales | 6.72 |
| Price / Book | 4.66 |
| 52 Weeks Range | |
| Earnings Date | 4 Aug 2026 |
| Profit Margin | -62.50% |
| Operating Margin (TTM) | -69.33% |
| Diluted EPS (TTM) | -1.25 |
| Quarterly Revenue Growth (YOY) | 42.30% |
| Total Debt/Equity (MRQ) | 12.03% |
| Current Ratio (MRQ) | 17.36 |
| Operating Cash Flow (TTM) | -36.90 M |
| Levered Free Cash Flow (TTM) | -26.02 M |
| Return on Assets (TTM) | -17.46% |
| Return on Equity (TTM) | -41.39% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Bearish |
| Medical Devices (Global) | Mixed | Bearish | |
| Stock | CeriBell, Inc. | Bullish | Bearish |
AIStockmoo Score
| Analyst Consensus | 2.0 |
| Insider Activity | -2.5 |
| Price Volatility | -2.0 |
| Technical Moving Averages | -2.5 |
| Technical Oscillators | -0.5 |
| Average | -1.10 |
|
CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, highly portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| % Held by Insiders | 10.54% |
| % Held by Institutions | 84.45% |
No data within this time range.
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| CHAO XINGJUAN | - | 18.14 | -39,000 | -707,460 |
| TAYLOR JOSEPH MICHAEL | - | 18.15 | -5,500 | -99,825 |
| Aggregate Net Quantity | -44,500 | |||
| Aggregate Net Value ($) | -807,285 | |||
| Aggregate Avg. Buy ($) | - | |||
| Aggregate Avg. Sell ($) | 18.15 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| TAYLOR JOSEPH MICHAEL | Director | 11 Jun 2026 | Sell (-) | 5,500 | 18.15 | 99,825 |
| CHAO XINGJUAN | Officer | 08 Jun 2026 | Automatic sell (-) | 39,000 | 18.14 | 707,460 |
| CHAO XINGJUAN | Officer | 08 Jun 2026 | Option execute | 25,000 | - | - |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |